Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival

Hemasphere. 2022 Sep 27;6(10):e781. doi: 10.1097/HS9.0000000000000781. eCollection 2022 Oct.

Michael Winkelmann¹, Kai Rejeski², Viktoria Blumenberg², Veit L Bücklein², Michael Ruzicka², Marcus Unterrainer¹, Christian Schmidt², Franziska J Dekorsy³, Peter Bartenstein^{3

4}, Jens Ricke^{1

4}, Michael von Bergwelt-Baildon^{2

4}, Marion Subklewe^{2

4}, Wolfgang G Kunz^{1

4}

No abstract available